<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Prader-Willi syndrome is characterized by <z:mp ids='MP_0004144'>hypotonia</z:mp> and <z:hpo ids='HP_0011968'>feeding difficulties</z:hpo> in the neonatal period, with the childhood development of <z:hpo ids='HP_0002591'>hyperphagia</z:hpo> leading to <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0001263'>developmental delay</z:hpo>, <z:hpo ids='HP_0000135'>hypogonadism</z:hpo>, <z:hpo ids='HP_0004322'>short stature</z:hpo> and small hands and feet </plain></SENT>
<SENT sid="1" pm="."><plain>Correct diagnosis of Prader-Willi syndrome is important because of its clinical implications and the need for family genetic counseling </plain></SENT>
<SENT sid="2" pm="."><plain>In order to determine the most efficient method of diagnosing the condition, we evaluated 37 patients with a putative diagnosis of Prader-Willi syndrome by both clinical and molecular cytogenetic analyses </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical evaluation showed that 25 patients fulfilled the diagnostic criteria for Prader-Willi syndrome </plain></SENT>
<SENT sid="4" pm="."><plain>A deletion of the region 15q11.2-13 was cytogenetically identified in 20 patients using a high-resolution technique </plain></SENT>
<SENT sid="5" pm="."><plain>Four additional cases were detected by fluorescence in situ hybridization (FISH) with the cosmid probes for D15S11, r-aminobutyric acid receptor beta 3 (GABRB3), small nuclear ribonucleoprotein-associated <z:chebi fb="7" ids="16670">peptide</z:chebi> N (SNRPN) or D15S10 (Prader-Willi/ <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> region probes) </plain></SENT>
<SENT sid="6" pm="."><plain>The deletion of SNRPN was documented in 24 Prader-Willi syndrome patients </plain></SENT>
<SENT sid="7" pm="."><plain>Only one additional patient with typical Prader-Willi syndrome features did not have any deletion over 15q11-13 at either the cytogenetic or molecular level </plain></SENT>
<SENT sid="8" pm="."><plain>FISH provides a more reliable method than high-resolution chromosome analysis for the diagnosis of Prader-Willi syndrome </plain></SENT>
<SENT sid="9" pm="."><plain>Associated conditions such as <z:hpo ids='HP_0001010'>hypopigmentation</z:hpo>, small-<z:hpo ids='HP_0001388'>joint laxity</z:hpo>, <z:hpo ids='HP_0001166'>arachnodactyly</z:hpo>, <z:hpo ids='HP_0001250'>seizure</z:hpo> disorder, <z:hpo ids='HP_0000648'>optic atrophy</z:hpo>, <z:hpo ids='HP_0002564'>congenital heart disease</z:hpo>, <z:e sem="disease" ids="C0023234" disease_type="Disease or Syndrome" abbrv="">Perthes' disease</z:e>, <z:hpo ids='HP_0001007'>hirsutism</z:hpo>, <z:hpo ids='HP_0000483'>astigmatism</z:hpo>/<z:hpo ids='HP_0000646'>amblyopia</z:hpo>, <z:hpo ids='HP_0000252'>microcephaly</z:hpo> and neuropsychiatric disturbances dictate the effects of a <z:hpo ids='HP_0001466'>contiguous gene syndrome</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Morbidity is high among patients with <z:hpo ids='HP_0001513'>obesity</z:hpo> and associated conditions </plain></SENT>
<SENT sid="11" pm="."><plain>Appropriate genetic counseling should be given to the parents and dietary management should be helpful for patients with Prader-Willi syndrome </plain></SENT>
</text></document>